Search Results (131)

Background and Objectives: Magnesium (Mg)-based materials, such as the WE43 alloy, show potential in biomedical applications owing to their advantageous mechanical properties and biodegradability; however, their quick corrosion rate and hydrogen release restrict their general clinical utilization. This study aimed to develop a novel Mg-Zn-Ca alloy system based on WE43 alloy, evaluating the influence of Zn and Ca additions on microstructure, mechanical properties, cytocompatibility, and electrochemical behavior for potential use in biodegradable orthopedic applications. Materials and Methods: The WE43-Zn-Ca alloy system was developed by alloying standard WE43 (Mg–Y–Zr–RE) with 1.5% Zn and Ca concentrations of 0.2% (WE43_0.2Ca alloy) and 0.3% (WE43_0.3Ca alloy). Microstructural analysis was performed utilizing scanning electron microscopy (SEM) in conjunction with energy-dispersive X-ray spectroscopy (EDS), while the chemical composition was validated through optical emission spectroscopy and X-ray diffraction (XRD). Mechanical properties were assessed through tribological tests. Electrochemical corrosion behavior was evaluated using potentiodynamic polarization in a 3.5% NaCl solution. Cytocompatibility was assessed in vitro on MG63 cells using cell viability assays (MTT). Results: Alloys WE43_0.2Ca and WE43_0.3Ca exhibited refined, homogeneous microstructures with grain sizes between 70 and 100 µm, without significant structural defects. Mechanical testing indicated reduced stiffness and an elastic modulus similar to human bone (19.2–20.3 GPa), lowering the risk of stress shielding. Cytocompatibility tests confirmed non-cytotoxic behavior for alloys WE43_0.2Ca and WE43_0.3Ca, with increased cell viability and unaffected cellular morphology. Conclusions: The study validates the potential of Mg-Zn-Ca alloys (especially WE43_0.3Ca) as biodegradable biomaterials for orthopedic implants due to their favorable combination of mechanical properties, corrosion resistance, and cytocompatibility. The optimization of these alloys contributed to obtaining an improved microstructure with a reduced degradation rate and a non-cytotoxic in vitro outcome, which supports efficient bone tissue regeneration and its integration into the body for complex biomedical applications. Full article

Magnesium-based biomaterials have emerged as highly promising candidates in the realm of biomedical engineering due to certain unique properties. However, their widespread application has been limited by a number of challenges, such as insufficient mechanical strength and rapid degradation rates. This study sought to advance the development of high-performance magnesium alloys by examining the microstructural evolution and associated strengthening mechanisms of Mg-Zn alloys modified with varying Nd contents. Comprehensive characterization techniques—including optical microscopy, XRD, and SEM/EDS—were employed to explain the influence of Nd additions on the microstructures. Mechanical performance was assessed through hardness testing, the RFDA method for elastic modulus, and tensile testing. The microstructural analysis of the as-cast Mg-Zn-Nd alloys revealed a complex phase composition comprising dendritic α-Mg, Mg₄₁Nd₅, and a Mg₃Nd binary phase enriched with rare earth elements. Notably, increasing the Nd content from 0.5% to 5% by weight resulted in a significant enhancement of hardness, reaching 59 HV compared to 42 HV in the base alloy. The tensile strength increased significantly from 62.9 MPa in the Mg-2.5Zn-0.5Nd alloy to 186.8 MPa in the Mg-2.5Zn-5Nd alloy. The elastic modulus values across all investigated alloys remained consistently comparable, which is expected as the elastic modulus is primarily determined by atomic bonding and is not significantly affected by alloying additions. These findings underscore the potential of Nd-alloyed Mg-Zn systems as viable, mechanically robust alternatives for next-generation biodegradable orthopedic implants. Full article

This study systematically investigated the effects of biologically relevant microalloying elements—calcium (Ca), strontium (Sr), manganese (Mn), and zirconium (Zr)—on the electrochemical behavior of Mg-Y-Zn alloys containing long-period stacking ordered (LPSO) phases. The alloys were prepared by casting and characterized using X-ray diffraction (XRD), optical microscopy (OM), and scanning electron microscopy with energy-dispersive spectroscopy (SEM/EDS). Electrochemical properties were assessed through potentiodynamic polarization in Hank’s solution, and corrosion rates were determined by hydrogen evolution and weight loss methods. Microalloying significantly enhanced the corrosion resistance of the base Mg-Y-Zn alloy, with corrosion rates decreasing from 2.67 mm/year (unalloyed) to 1.65 mm/year (Ca), 1.36 mm/year (Sr), 1.18 mm/year (Zr), and 1.02 mm/year (Mn). Ca and Sr additions introduced Mg₂Ca and Mg₁₇Sr₂, while Mn and Zr refined the existing LPSO structure without new phases. Sr refined the LPSO phase and formed a uniformly distributed Mg₁₇Sr₂ network, promoting uniform corrosion and suppressing deep localized attacks. Ca-induced Mg₂Ca acted as a temporary sacrificial phase, with corrosion eventually propagating along LPSO interfaces. The Mn-containing alloy exhibited the lowest corrosion rate; this is attributed to the suppression of both anodic and cathodic reaction kinetics and the formation of a stable protective surface film. Zr improved general corrosion resistance but increased susceptibility to localized attacks due to dislocation-rich zones. These findings elucidate the corrosion mechanisms in LPSO-containing Mg alloys and offer an effective strategy to enhance the electrochemical stability of biodegradable Mg-based implants. Full article

Biodegradable metallic implants represent a paradigm shift in implantology, eliminating secondary removal surgeries through predictable controlled degradation. This review systematizes current achievements in selective laser melting (SLM) of biodegradable metals (Mg, Fe, Zn), analyzing how processing parameters influence microstructure, mechanical properties, and degradation kinetics. Key findings demonstrate that SLM-produced Mg alloys achieve bone-matching modulus (40–45 GPa) with moderate degradation (1–3 mm/year); Fe-based systems provide superior strength (400–600 MPa) but slower degradation (0.1–0.5 mm/year); while Zn alloys offer intermediate properties. Design strategies for porous/lattice structures enhancing osseointegration and enabling property gradients are discussed. Major challenges include controlling degradation kinetics, optimizing SLM parameters for reactive metals, standardizing testing methodologies, and regulatory harmonization. This comprehensive analysis provides systematic guidelines for material selection and process optimization, establishing a foundation for developing next-generation personalized biodegradable implants. Full article

The growing prevalence of bacterial infections and the alarming rise of antimicrobial resistance (AMR) have driven the need for innovative antimicrobial coatings for medical implants and biomaterials. However, implant surface properties, such as roughness, chemistry, and reactivity, critically influence biological interactions and must be engineered to ensure biocompatibility, corrosion resistance, and sustained antibacterial activity. This review evaluates three principal categories of antimicrobial agents utilized in surface functionalization: metal/metaloxide nanoparticles, antibiotics, and phytochemical compounds. Metal/metaloxide-based coatings, especially those incorporating silver (Ag), zinc oxide (ZnO), and copper oxide (CuO), offer broad-spectrum antimicrobial efficacy through mechanisms such as reactive oxygen species (ROS) generation and bacterial membrane disruption, with a reduced risk of resistance development. Antibiotic-based coatings enable localized drug delivery but often face limitations related to burst release, cytotoxicity, and diminishing effectiveness against multidrug-resistant (MDR) strains. In contrast, phytochemical-derived coatings—using bioactive plant compounds such as curcumin, eugenol, and quercetin—present a promising, biocompatible, and sustainable alternative. These agents not only exhibit antimicrobial properties but also provide anti-inflammatory, antioxidant, and osteogenic benefits, making them multifunctional tools for implant surface modification. The integration of these antimicrobial strategies aims to reduce bacterial adhesion, inhibit biofilm formation, and enhance tissue regeneration. By leveraging the synergistic effects of metal/metaloxide nanoparticles, antibiotics, and phytochemicals, next-generation implant coatings hold the potential to significantly improve infection control and clinical outcomes in implant-based therapies. Full article

Biodegradable magnesium-based composites show potential application in orthopedic implants, with excellent biocompatibility, low density, and biodegradable characteristics inside the human body. In this study, the stir casting procedure was employed to produce magnesium–zinc MMCs (metal matrix composites) reinforced with MgO nanoparticles, and they were characterized intensively. The analyzed compositions were Mg/4Zn, Mg/4Zn/0.4MgO, and Mg/4Zn/0.6MgO. Their mechanical properties, corrosion resistance, and microstructure were then investigated employing tensile, impact, hardness, wear, and corrosion tests, supplemented with SEM analysis. The results indicate that the Mg-4Zn-0.6MgO composite exhibited the highest performance among the tested formulations, with a tensile strength of 150 MPa, a hardness of 65 HRE (Rockwell Hardness, E-scale), and enhanced corrosion resistance. These improvements are attributed to the uniform dispersion of MgO nanoparticles and the formation of a protective Mg(OH)₂ layer, which together contribute to mechanical reinforcement and controlled degradation behavior. The combination of superior mechanical properties and customizable biodegradability verifies the engineered Mg/4Zn/0.6MgO composite as a promising candidate for a biodegradable orthopedic fixation plate without secondary surgery. Full article

Zn-Ag alloys are deemed extremely promising materials for manufacturing biodegradable medical implants. Nonetheless, their practical applications are still constrained by inferior mechanical properties. To tackle this issue, Zn-0.5Ag alloy was alloyed with Mg (0.2 wt.%) and processed by combined equal-channel angular pressing (ECAP) and rolling, with different rolling reductions (40%, 60%, and 75%). ECAP-processed Zn-0.5Ag-0.2Mg alloy exhibited superior mechanical properties to its as-cast counterpart. Subsequent rolling of 40% further enhances the mechanical performance of ECAP-processed Zn-0.5Ag-0.2Mg alloy, with yield strength (YS), ultimate tensile strength (UTS), and elongation (EL) reaching 255 MPa, 309 MPa, and 52%, respectively, surpassing the application requirements. As the rolling reduction increased to 60% and further to 75%, YS and UTS declined, whereas EL rose continuously. The underlying mechanisms for the variation in strength and ductility were elucidated based on microstructure evolution analysis through optical microscopy (OM), scanning electron microscopy (SEM), and electron backscatter diffraction (EBSD) characterizations. Full article

Zinc (Zn)-based alloys are considered promising bioresorbable materials for intracorporeal implants due to their good biocompatibility and suitable degradation rate in physiological environments. However, their broader application is hindered by insufficient mechanical properties, which are essential for fulfilling the therapeutic function of bioresorbable implants. This study investigates the effect of severe plastic deformation on the microstructure and mechanical properties of as-cast Zn–0.1Mg (wt.%) alloy. The as-cast alloy, characterised by a coarse-grained microstructure with intermetallic phases at grain boundaries and low strength and ductility, was subjected to two passes of Equal Channel Angular Pressing (ECAP). The intense plastic deformation transformed the coarse-grained structure into an ultrafine-grained solid solution matrix. This substantial microstructural refinement led to a significant enhancement in mechanical performance. The yield strength (YS) and ultimate tensile strength (UTS) more than doubled, reaching 198 MPa and 215 MPa, respectively. Remarkably, the elongation increased from 2.2% to 187% in tensile testing. These findings confirm the beneficial effect of grain refinement and dynamic recrystallisation on the mechanical behaviour of bioresorbable Zn–0.1Mg alloy and highlight the high potential of ECAP processing for optimising the mechanical properties of Zn-based biodegradable materials. Full article

Mg–Zn–Mn-based biocomposites hold prospects as potential orthopedic material. The composition of these composites can be modulated, based on applications, by selective elemental alloying. Towards that, the addition of silicon (Si), hydroxyapatite (HA), or both is considered, followed by the consolidation method, such as spark plasma sintering (SPS). In this study, the micro-mechanical properties of Mg–Zn–Mn–(Si–HA) composites were investigated through the micro-pillar compression method. The effect of Si and HA incorporation on the mechanical characteristics and deformation mechanism was also elucidated. The microstructure of the composite presents porosity, together with different bioactive phases, such as Mg–Zn, CaMg, Mn–P, MgSi₂, Mn–Si, Mn–CaO, CaMgSi, and Ca–Mn–O. Such porous structures were determined to facilitate cell growth when used as an implant, particularly for musculoskeletal-related disabilities. The yield stress (YS) and compressive stress of the Mg–Zn–Mn–Si–HA were about 1543 ± 99 MPa and 1825 ± 102 MPa, respectively. These values were about 5.8 and 4.8 times higher, respectively, than those of Mg–Zn–Mn–HA composites (266 ± 42 MPa and 380 ± 10 MPa, respectively), and the same was observed for the elastic modulus. Besides that, alloying with HA and Si alters the deformation mechanism from brittle (for Mg–Zn–Mn–Si composites) or ductile (for Mg–Zn–Mn–HA composites) to predominant ductile failure without compromising the attained mechanical properties. Full article

In this study, a graphene oxide (GO)/zinc oxide (ZnO)/hydroxyapatite (nHAp) composite coating was constructed on a pure titanium surface by microarc oxidation (MAO) pretreatment combined with hydrothermal technology (HT), thereby making it possible to explore the performance optimization of this coating for Ti-based implants. Scanning electron microscopy (SEM), an energy dispersion spectrometer (EDS), Fourier transform infrared spectroscopy (FTIR), Ramam spectroscopy (Ramam), etc., confirmed that the GO/ZnO/nHAp composites were successfully loaded onto the pure Ti surfaces. Through nanoindentation, differential thermal analysis (DiamondTG/DTA), and dynamic polarization potential detection, the GO/ZnO/nHAp composite coating imparts excellent nanohardness (2.7 + 1.0 GPa), elastic modulus (53.5 + 1.0 GPa), thermal stability, and corrosion resistance to pure Ti implants; hemolysis rate analysis, CCK-8, alkaline phosphatase (ALP) detection, alizarin red staining, and other experiments further show that the coating improves the hemocompatibility, biocompatibility, and bone guidance of the Ti implant surface. Studies have shown that GO/ZnO/nHAp composite coatings can effectively optimize the mechanical properties, corrosion resistance, biocompatibility, and bone guidance of pure Ti implants, so that they can obtain an elastic modulus that matches human bone. Full article

Mg₆₆Zn₃₀Ca₄ metallic glass is a promising biodegradable material due to its high strength, corrosion resistance, and excellent glass-forming ability. In this study, we investigated its thermal stability, structural relaxation, and crystallization behavior using high-energy synchrotron-based X-ray diffraction and DSC analysis. The glass exhibits a wide supercooled liquid region of 58 K, allowing for thermoplastic forming. Structural relaxation experiments revealed nearly a complete relaxation in the first cycle below the first crystallization peak. Upon heating, the alloy undergoes a complex, multi-step devitrification involving successive formation of crystalline phases: Mg₅₁Zn₂₀ (orthorhombic), Mg (hexagonal), and a Ca–Mg–Zn intermetallic compound Ca₈Mg_26.1Zn_57.9, denoted as IM3. Phase identification was carried out by Rietveld refinement, and the evolution of lattice parameters demonstrated anisotropic thermal expansion, particularly in the Mg₅₁Zn₂₀ phase. Notably, the presence of the IM1 Ca₃Mg_xZn_15−x, with the 4.6 ≤ x ≤ 12 phase reported in earlier studies, was not confirmed. This work deepens the understanding of phase stability and crystallization mechanisms in Mg-based metallic glasses and supports their future application in biodegradable implants. Full article

Background: This study examined how the concentration of calcium (Ca) influences the microstructure, mechanical characteristics, and tribological attributes of Mg–Ca–Zn–RE–Zr alloys for orthopedic medicine. Materials and methods: Experimental alloys with 0.1 and 0.5 wt% Ca were prepared in a controlled atmosphere induction furnace. The microstructure of the alloys was investigated by scanning electron microscopy, the chemical composition by X-ray fluorescence and energy-dispersive spectroscopy, the mechanical properties by indentation and scratching, and the corrosion resistance by linear and cyclic potentiometry. Results: The alloy with 0.1% Ca exhibited greater fluctuations in the coefficient of friction, while the sample with 0.5% Ca showed a higher susceptibility to cracking. Regarding corrosion resistance, both samples exhibited a generalized corrosion trend with similar corrosion currents. At lower Ca concentrations (0.1%), the refined microstructure of the alloys provided an elastic modulus closer to that of human bone, minimizing the risk of excessive local stress and promoting uniform load distribution at the bone-implant interface. Conclusion: The 0.5% Ca alloy offered superior tribological stability and better shock absorption, making it suitable for applications requiring long-term stability. The study highlighted the potential of both compositions based on the specific requirements of biodegradable orthopedic implants. Full article

In the field of degradable metals, Zn-based implants have gradually gained more attention. However, the relatively slow degradation rate compared with the healing rate of the damaged bone tissue, along with the excessive Zn²⁺ release during the degradation process, limit the application of Zn-based implants. The use of intermetallic compounds with more negative electrode potentials as sacrificial anodes of Zn-based implants is likely to be a feasible approach to resolve this contradiction. In this work, three intermetallic compounds, MgZn₂, CaZn₁₃, and Ca₂Mg₆Zn₃, were prepared. The phase structures, microstructures, and relevant properties, such as thermal stability, in vitro degradation properties, and cytotoxicity of the compounds, were investigated. The XRD patterns indicate that the MgZn₂ and CaZn₁₃ specimens contain single-phase MgZn₂ and CaZn₁₃, respectively, while the Ca₂Mg₆Zn₃ specimen contains Mg₂Ca and Ca₂Mg₆Zn₃ phases. After purifying treatment in 0.9% NaCl solution, high purity Ca₂Mg₆Zn₃ phase was obtained. Thermal stability tests suggest that the MgZn₂ and CaZn₁₃ specimens possess good thermal stability below 773 K. However, the Ca₂Mg₆Zn₃ specimen melted at around 739.1 K. Polarization curve tests show that the corrosion potentials of MgZn₂, CaZn₁₃, and Ca₂Mg₆Zn₃ in simulated body fluid (SBF) were −1.063 V_SCE, −1.289 V_SCE, and −1.432 V_SCE, which were all more negative than that of the pure Zn specimen (−1.003 V_SCE). Clearly, these compounds can act as sacrificial anodes in Zn-based implants. The immersion tests indicate that these compounds were degraded according to the atomic ratio of the elements in each compound. Besides that, the compounds can efficiently induce Ca-P deposition in SBF. Cytotoxicity tests demonstrate that the 10% extracts prepared from these compounds exhibit good cell activity on MC3T3-E1 cells. Full article

Millions of people request bone regeneration every year, and the market for bone grafting materials has a positive trend. The most used biomaterials applied to replace and regenerate bone are based on collagen and different types of ceramics in order to mimic natural bone matrix. However, there are a lot of implant-associated infections after surgery, or the implants are rejected because of reduced biocompatibility, and this is why the research into graft bone materials is still a challenge. This study aims to develop and characterize novel biomimetic bone fillers which have simultaneously both antimicrobial properties and biocompatibility with human bone marrow—derived mesenchymal stem cells (BMSCs). Type I collagen and calcium triphosphate in a ratio of 1:1 were used as a control, according to our previous studies, and ZnO, functionalized with different percentages of Satureja thymbra L. essential oils, was added as an antimicrobial, promoting bone growth, mineralization, and formation. The bone fillers were obtained by freeze-drying in spongious forms and characterized by Fourier Transform Infrared Spectroscopy (FT-IR), Scanning Electron Microscopy (SEM), water uptake, biodegradability over time, antimicrobial activity against Staphylococcus aureus and Escherichia coli and viability and proliferation of human BMSCs. The graft material showed a higher porosity with interconnected pores, gradual resorption over time and a balance between antimicrobial properties and biocompatibility and was chosen as an ideal bone filler. Full article

The rising prevalence of orthopedic conditions, driven by an aging population, has led to a growing demand for advanced implant materials. Traditional metals such as stainless steel and titanium alloys are biologically inert and often necessitate secondary surgical removal, imposing both economic and psychological burdens on patients. Biodegradable zinc-based alloys offer promising alternatives due to their moderate degradation rates, biocompatibility, and tissue-healing properties. However, existing studies on Zn-Fe alloys primarily focus on composition optimization, with limited investigation into how processing methods influence their performance. This study explores the effects of rotary forging on the microstructure and mechanical properties of Zn-0.5Fe alloys. By refining grain structure and promoting dynamic recrystallization, rotary forging achieves significant improvements in ductility (60% elongation, a 114% increase compared to the extruded state) while maintaining corrosion resistance. Electrochemical and immersion tests reveal that rotary forging produces a denser and more protective corrosion layer, thereby improving the degradation performance of the material in simulated body fluid. Cytotoxicity and fluorescence staining tests confirm excellent biocompatibility, validating the material’s suitability for medical applications. These findings elucidate the mechanisms by which rotary forging enhances the properties of Zn-0.5Fe alloys, providing a novel approach to tailoring biodegradable implant materials for orthopedic applications. Full article